4Homyak M, Digre K, Couldwell WT. Neuro-ophthalmologi- cal manifestations of benign anterior skull base lesions. Post- grad Med, 2009, 121(4) :103-114.
5Van Stavem GP, Newman NJ. Optic neuropathies. An over- view. Ophthalmol Clin of North Am, 2001,14 (1) : 61- 71.
6Behbehani R. Clinical approach to optic neuropathies. Clin Ophthalmol, 2007, 1 (3) : 233 -246.
8Thomas R, Shenoy K, Seshadri MS, et al. Visual field de- fects in non-functioning pituitary adenomas. Indian J Ophthal- mol, 2002, 50(2) : 127-130.
9Colao A, Di Somma C, Pivonello R, et al. Medical therapy for clinically non-functioning pituitary adenomas. Endoer Relat Cancer, 2008, 15(4) : 905-915.
10Ho RW, Huang HM, Ho JT, et al. The influence of pituitary adenoma size on vision and visual outcomes after trans-sphe- noidal adenectomy : a report of 78 cases. J Korean Neurosurg Soc, 2015, 57(1) : 23-31.
2Li C, Xiao Z Q, Chen Z C, et al. Proteome analysis of human lung squamous carcinoma [ J ] . Proteomies, 2006 , 6(2) : 547-558.
3Corbett J M, Dunn M J, Poseh A, et al. Positional reproducibility of protein spots in two-dimensional polyacrylamide gel electrophoresis using immobilized pH gradients isoelectric focusing in the first dimension: An interlaboratory comparison [J]. Electrophoresis, 1994, 15 (11) :1205-1211.
4Beranova-Giorgianni S, Giorgianni F, Desiderio D M, et al. Analysis of the proteome in the human pituitary [ J ] . Proteomics, 2002, 2 (5): 534-542.
5Desiderio D M, Zhan X Q. The human pituitary proteome : the characterization of differentially expressed proteins in an adenoma compared to a control [ J ]. Cell Mol Biol, 2003, 49(5) : 689-712.
6Zhan X Q, Desiderio D M. A reference map of a human pituitary adenoma proteome [ J ] . Proteomics, 2003 , 3 (5) : 699-713.
7Kedar S, Ghate D, Corbett JJ, et al. Visual fields in neuroophthalmology [ J ]. Indian J Ophthalmol, 2011,59 ( 2 ) : 103-109.
8Kawamata T, Iseki H, Ishizaki R. Minimally invasive endoscopeassisted endonasal trans-sphenoidal microsurgery for pituitary tumors: experience with 215 cases comparing with sublabial trans-sphenoidal approach [ J ]. Neurol Res, 2002,24 ( 3 ) : 259 -265.
9Berkmann S, Fandino J, Zosso S, et al. Intraoperative magnetic imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions [ J]. J Neurosurg, 2011, 115(3) :518-527.
10Murad MH, FernCmdez-Balsells MM, Barwise A, et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis [ J]. Clin Endocrinol ( Oxf), 2010,73 (6) :777-791.
